Qureshi Mahir, Alabd Andrew, Behling Eric, Schwarting Roland, Haroldson Kathryn
Department of Medicine, Cooper Medical School of Rowan University, Camden, USA.
Department of Medicine, Cooper University Hospital, Camden, USA.
Cureus. 2022 Mar 24;14(3):e23455. doi: 10.7759/cureus.23455. eCollection 2022 Mar.
Hemophagocytic lymphohistiocytosis (HLH) is an aggressive hematologic disorder involving hyperstimulation of immune responses and severe inflammation. HLH has been well documented in lymphoid cancers and leukemias, but more rarely in solid tumors. The non-specific clinical characteristics of HLH can cause a diagnostic dilemma and delay in proper treatment, resulting in poor outcomes. We present a case of a patient with metastatic renal cell carcinoma who developed unexplained acute liver failure and was later found to have HLH. This case highlights the importance of including this syndrome on the differential diagnosis for acute liver failure of indeterminate cause and cytopenia in the setting of malignancy to facilitate proper timely treatment to improve outcomes and increase odds of survival.
噬血细胞性淋巴组织细胞增生症(HLH)是一种侵袭性血液系统疾病,涉及免疫反应的过度刺激和严重炎症。HLH在淋巴癌和白血病中已有充分记录,但在实体瘤中较少见。HLH的非特异性临床特征可能导致诊断困境和适当治疗的延迟,从而导致不良预后。我们报告一例转移性肾细胞癌患者,该患者出现不明原因的急性肝衰竭,后来被发现患有HLH。该病例强调了在恶性肿瘤背景下,对于原因不明的急性肝衰竭和血细胞减少症的鉴别诊断中纳入该综合征的重要性,以便及时进行适当治疗,改善预后并提高生存几率。